Tropic raises €91.3m in a Series C round to scale gene-edited tropical crop production.
The financing was co-led by Forbion and Corteva to accelerate the commercial rollout of disease-resistant banana varieties.
≈ £79.1M at €1 = £0.8664 on 13 Mar 2026
Norwich-based agricultural biotechnology startup developing gene-edited tropical crops to enhance global food security.
Norwich-based agricultural biotechnology startup Tropic has secured €91.3m in a Series C financing round to scale its gene-edited tropical crop portfolio. The investment was co-led by Forbion and Corteva, with participation from Just Climate, IQ Capital, ABN Amro, Invest International, Temasek, Five Seasons Ventures, Sucden Ventures, Genoa Ventures, and Polaris Partners.
The capital will support the commercial rollout of the company's banana varieties designed to resist diseases such as Panama Disease and Black Sigatoka, alongside the expansion of its rice research programme.
Tropic recently launched commercial banana varieties including non-browning fruit and types with extended shelf life. The fresh funds provide the resources needed to broaden international distribution and advance plant production capacity.
From the founder
"This funding is a powerful endorsement of our team’s ability to bring breakthrough products to the hands of growers, exporters and consumers around the world. We are entering a new era, one where gene‑edited crops will significantly enhance food security and sustainability. 2025 proved that our technology delivers – not in the distant future, but right now. With two banana varieties already on the market and demand outstripping supply, this investment enables us to scale global production and expand into new crops faster than ever before. We are excited to be partnering with our new investors as we progress our mission to build a world-leading tropical seeds company."
Gilad Gershon
CEO at Tropic
Use of funds
- 01Continue product development
- 02Expand into international markets
Investors
Forbion
Corteva
Just Climate
IQ Capital
Invest International
Temasek
Five Seasons Ventures
Sucden Ventures
Genoa Ventures
Polaris Partners